These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1526691)

  • 21. Optimum allocation of treatments for Welch's test in equivalence assessment.
    Dette H; Munk A
    Biometrics; 1997 Sep; 53(3):1143-50. PubMed ID: 9333344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of pharmacokinetic interaction as an equivalence problem.
    Steinijans VW; Hartmann M; Huber R; Radtke HW
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S25-30. PubMed ID: 8793601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanded confidence intervals, one-sided tests, and equivalence testing.
    Bofinger E
    J Biopharm Stat; 1992; 2(2):181-8. PubMed ID: 1300212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of outlying subjects on decision of bioequivalence.
    Ki FY; Liu JP; Wang W; Chow SC
    J Biopharm Stat; 1995 Mar; 5(1):71-94. PubMed ID: 7613561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential designs for equivalence studies.
    Whitehead J
    Stat Med; 1996 Dec; 15(24):2703-15. PubMed ID: 8981681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Review and use of decision rules for bioequivalence trials].
    Nicolas P; Tod M; Petitjean O
    Therapie; 1993; 48(1):15-22. PubMed ID: 8356540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the means and variances of a bivariate log-normal distribution.
    Bebu I; Mathew T
    Stat Med; 2008 Jun; 27(14):2684-96. PubMed ID: 17907261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Types of bioequivalence and related statistical considerations.
    Hauck WW; Anderson S
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):181-7. PubMed ID: 1592546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robust and bootstrap testing procedures for bioequivalence.
    Shen CF; Iglewicz B
    J Biopharm Stat; 1994 Mar; 4(1):65-90. PubMed ID: 8019585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Average bioequivalence of two oral formulations of fluconazole in healthy subjects after multiple dosing.
    Atanasova I; Bozhinova K; Terziivanov D
    Int J Clin Pharmacol Ther; 1999 Jun; 37(6):282-5. PubMed ID: 10395119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy in parameter estimation for targeted effects in structural equation modeling: sample size planning for narrow confidence intervals.
    Lai K; Kelley K
    Psychol Methods; 2011 Jun; 16(2):127-48. PubMed ID: 21417531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Review of statistical procedures for determining the equivalency of two treatments].
    Com-Nougue C; Rodary C
    Rev Epidemiol Sante Publique; 1987; 35(5):416-30. PubMed ID: 3324228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sample size determination for matched-pair equivalence trials using rate ratio.
    Tang NS; Tang ML; Wang SF
    Biostatistics; 2007 Jul; 8(3):625-31. PubMed ID: 17071862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multivariate test for population bioequivalence.
    Chervoneva I; Hyslop T; Hauck WW
    Stat Med; 2007 Mar; 26(6):1208-23. PubMed ID: 16810712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individual bioequivalence: what matters to the patient.
    Hauck WW; Anderson S
    Stat Med; 1991 Jun; 10(6):959; discussion 959-60. PubMed ID: 1876785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sample sizes for clinical trials with normal data.
    Julious SA
    Stat Med; 2004 Jun; 23(12):1921-86. PubMed ID: 15195324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presentation of the intrasubject coefficient of variation for sample size planning in bioequivalence studies.
    Hauschke D; Steinijans WV; Diletti E; Schall R; Luus HG; Elze M; Blume H
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):376-8. PubMed ID: 7952801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro bioequivalence testing.
    Chow SC; Shao J; Wang H
    Stat Med; 2003 Jan; 22(1):55-68. PubMed ID: 12486751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variation of Cmax and Cmax/AUC in investigations of bioequivalence.
    Endrenyi L; Yan W
    Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):184-9. PubMed ID: 8500920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
    Hirotsu C
    Pharm Stat; 2007; 6(3):193-203. PubMed ID: 17879327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.